Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 341

1.

Translocations of the RARalpha gene in acute promyelocytic leukemia.

Zelent A, Guidez F, Melnick A, Waxman S, Licht JD.

Oncogene. 2001 Oct 29;20(49):7186-203. Review.

PMID:
11704847
[PubMed - indexed for MEDLINE]
Free Article
2.

Transcription therapy for acute promyelocytic leukaemia.

Douer D.

Expert Opin Investig Drugs. 2000 Feb;9(2):329-46. Review.

PMID:
11060680
[PubMed - indexed for MEDLINE]
3.

Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A.

Blood. 1998 Apr 15;91(8):2634-42.

PMID:
9531570
[PubMed - indexed for MEDLINE]
Free Article
4.

Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.

Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, Jin XL, Xiong SM, Zhu J, Guo WM, Chen JQ, Xu SF, So E, Chan LC, Waxman S, Zelent A, Chen GQ, Dong S, Liu JX, Chen SJ.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23.

PMID:
10339585
[PubMed - indexed for MEDLINE]
Free PMC Article
5.
6.

Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.

Nason-Burchenal K, Allopenna J, Bègue A, Stéhelin D, Dmitrovsky E, Martin P.

Blood. 1998 Sep 1;92(5):1758-67.

PMID:
9716606
[PubMed - indexed for MEDLINE]
Free Article
7.

Molecular pathogenesis of acute promyelocytic leukaemia and APL variants.

Sirulnik A, Melnick A, Zelent A, Licht JD.

Best Pract Res Clin Haematol. 2003 Sep;16(3):387-408. Review.

PMID:
12935958
[PubMed - indexed for MEDLINE]
8.

Acute promyelocytic leukemia: from clinic to molecular biology.

Chen SJ, Wang ZY, Chen Z.

Stem Cells. 1995 Jan;13(1):22-31. Review.

PMID:
7719245
[PubMed - indexed for MEDLINE]
9.

Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.

Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K.

Blood. 1998 Jul 15;92(2):374-82.

PMID:
9657734
[PubMed - indexed for MEDLINE]
Free Article
10.

Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.

Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E.

Blood. 1997 Dec 15;90(12):4876-85.

PMID:
9389704
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5302-7.

PMID:
9144232
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.

He LZ, Merghoub T, Pandolfi PP.

Oncogene. 1999 Sep 20;18(38):5278-92. Review.

PMID:
10498880
[PubMed - indexed for MEDLINE]
Free Article
14.

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.

Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.

Nature. 1998 Feb 19;391(6669):815-8.

PMID:
9486655
[PubMed - indexed for MEDLINE]
15.

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP.

Nat Genet. 1998 Feb;18(2):126-35.

PMID:
9462740
[PubMed - indexed for MEDLINE]
16.

Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.

Chen H, Pan J, Yao L, Wu L, Zhu J, Wang W, Liu C, Han Q, Du G, Cen J, Xue Y, Wu D, Sun M, Chen S.

Cancer Genet. 2012 Jun;205(6):327-31. doi: 10.1016/j.cancergen.2012.02.007.

PMID:
22749039
[PubMed - indexed for MEDLINE]
17.

Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.

Grimwade D, Solomon E.

Curr Top Microbiol Immunol. 1997;220:81-112. Review.

PMID:
9103677
[PubMed - indexed for MEDLINE]
18.

Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptors.

Côté S, McNamara S, Brambilla D, Bianchini A, Rizzo G, del Rincón SV, Grignani F, Nervi C, Miller WH Jr.

Blood. 2004 Dec 15;104(13):4226-35. Epub 2004 Aug 19.

PMID:
15319284
[PubMed - indexed for MEDLINE]
Free Article
19.

Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.

Hummel JL, Wells RA, Dubé ID, Licht JD, Kamel-Reid S.

Oncogene. 1999 Jan 21;18(3):633-41.

PMID:
9989813
[PubMed - indexed for MEDLINE]
Free Article
20.

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.

Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, Ley TJ, Gilliland DG.

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8283-8.

PMID:
12060771
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk